The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total EGR1 assay is a sandwich immunoassay for quantitative detection of total EGR1 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total EGR1 assay is a sandwich immunoassay for quantitative detection of total EGR1 in cellular lysates using Alpha Technology.
Loading...
Early Growth Response 1 (EGR1) is an immediate-early transcription factor that rapidly responds to diverse stimuli including growth factors, cytokines, and stress signals to regulate cell proliferation, differentiation, and apoptosis. EGR1 is induced within minutes of stimulation through MAPK and calcium signaling pathways, binding to GC-rich sequences in target gene promoters. EGR1 regulates expression of genes involved in cell cycle control (p53, PTEN), differentiation (fibronectin, PDGF), and vascular responses (VEGF, tissue factor). EGR1 functions as both a tumor suppressor and oncogene depending on cellular context, with loss of expression in prostate cancer and glioblastoma but overexpression in breast cancer. EGR1 plays critical roles in vascular injury responses, wound healing, and synaptic plasticity, making it relevant to cardiovascular disease, fibrosis, and neurological disorders.
The AlphaLISA SureFire Biotin-Free Human and Mouse Total EGR1 Detection Kit is a sandwich immunoassay for the quantitative detection of total EGR1 in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Biotin Free kits are compatible with:
AlphaLISA SureFire Biotin Free kits can be used for:
The Total-AlphaLISA Surefire Biotin Free assay measures the expression level of a protein target in a cell lysate.
The Total-AlphaLISA Surefire assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with a proprietary CaptSure 3 agent to capture one of the detection antibodies, which is labeled with CaptSure 3 tag. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well Optiplate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.
HeLa cells were seeded in a 96-well plate (40,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of EGF for 2 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). EGR1 and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, EGF triggered a dose-dependent increase in the levels of Total EGR1 while ERK Total levels remained unchanged.
RAW 264.7 cells were seeded in a 96-well plate (40,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of LPS for 2 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). EGR1 and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, LPS triggered a dose-dependent increase in the levels of Total EGR1 while ERK Total remained unchanged.
Jurkat cells were seeded in a 96-well plate (400,000 cells/well) in complete RPMI 1640 medium and treated with increasing concentrations of PMA for 3 hours.
After treatment, the cells were lysed with the addition of 50 µL of 5X Lysis Buffer for 10 minutes at RT with shaking (350 rpm). EGR1 and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 16,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, PMA triggered a dose-dependent increase in the levels of Total EGR1 while Total ERK remained unchanged.
EGR1 levels were assessed in HeLa wild type (WT) and EGR1 KO (Abcam, ab274929) cell lines cultured to confluency in T175 flasks and treated with 2 ng/mL EGF for 2 hours. Each flask was lysed in 4 mL of Lysis Buffer for 10 minutes at RT with shaking. Lysates were serially diluted in Lysis Buffer and levels of EGR1 Total were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate was transferred into a 384-well white OptiPlate, followed by 5 µL Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
EGR1 was only detected in WT cells, demonstrating assay specificity. Dotted line represents assay background.
Adherent cells were grown to confluency in a T175 flask at 37°C, 5% CO2 and were lysed with Lysis Buffer at a density of 0.5 x 106 cells/mL. Suspension cells were harvested, washed in HBSS and lysed with Lysis Buffer at 1.6 x 106 cells/mL.
EGR1 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (5,000 adherent and 16,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Biotin-Free
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
EGR1
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
NASH/Fibrosis
Oncology
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
Loading...
We are here to answer your questions.